Lumefantrine
Back to searchMolecule Structure
Scientific Name
Lumefantrine
Description of the Drug
Lumefantrine is an antimalarial agent used in combination with artemether for the treatment of acute uncomplicated malaria caused by Plasmodium falciparum.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06708
http://www.drugbank.ca/drugs/DB06708
Brand Name(s)
Not Available
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Ferriprotoporphyrin IX | SMALL MOLECULE | INHIBITOR | CHEMBL613897 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL127331 |
| PharmGKB | PA165111722 |
| Human Metabolome Database | HMDB0015653 |
| DrugBank | DB06708 |
| PubChem: Thomson Pharma | 14885370 |
| PubChem | 6437380 |
| Nikkaji | J3.642.651I |
| BindingDB | 50238630 |
| EPA CompTox Dashboard | DTXSID3046663 |
| DrugCentral | 1617 |
| ChemicalBook | CB7854882 |
| Guide to Pharmacology | 9969 |
| rxnorm | LUMEFANTRINE |
| ChEBI | 156095 |
